Picture of Bankers Investment Trust logo

BNKR Bankers Investment Trust News Story

0.000.00%
gb flag iconLast trade - 00:00
FinancialsConservativeMid Cap

REG - Bankers Investment - Half-year Report

For best results when printing this announcement, please click on link below:
https://newsfile.refinitiv.com/getnewsfile/v1/story?guid=urn:newsml:reuters.com:20250625:nRSY2373Oa&default-theme=true

RNS Number : 2373O  Bankers Investment Trust PLC  25 June 2025

LEGAL ENTITY IDENTIFIER: 213800B9YWXL3X1VMZ69
 

 

THE BANKERS INVESTMENT TRUST PLC

('the Company')

 

Unaudited results for the half-year ended 30 April 2025

 

This announcement contains regulated information

 

INVESTMENT OBJECTIVE

Over the long term, the Company aims to achieve capital growth in excess of
the FTSE World Index and dividend growth greater than inflation, as measured
by the UK Consumer Price Index ('CPI'), by investing in companies listed
throughout the world.

 

INVESTMENT POLICY

The following investment ranges apply:

·       Equities: 80% to 100%

·       Debt securities and cash investments: 0% to 20%

·       Investment trusts, collective funds and derivatives: 0% to 15%

 

To achieve an appropriate spread of investment risk the portfolio is broadly
diversified by geography, sector and company. The Manager ('Janus Henderson')
has the flexibility to invest in any geographic region and any sector with no
set limits on individual country or sector exposures and, therefore, the
make-up and weighting of the portfolio may differ materially from the FTSE
World Index.

 

The Manager primarily employs a bottom-up stock picking investment process,
across four regional portfolios, to identify suitable opportunities. While
each regional portfolio manager employs their own investment style, they all
pay particular regard to cash generation and dividend growth over the medium
term.

 

The Company can, but normally does not, invest up to 15% of its gross assets
in any other investment companies (including listed investment trusts).

 

Derivatives

The Company may use financial instruments known as derivatives for the purpose
of efficient portfolio management while maintaining a level of risk consistent
with the risk profile of the Company.

 

Gearing

The Company can borrow to make additional investments with the aim of
achieving a return that is greater than the cost of the borrowing. The Company
can borrow up to 20% of net assets at the time of draw down.

 

PERFORMANCE HIGHLIGHTS

                                                         30 April 2025  30 April 2024
 Net asset value ('NAV') per share(1)                    121.5p         125.5p
 Share price                                             109.6p         112.2p
 Revenue return per share                                1.16p          1.31p
 Dividends paid or declared in respect of the period(2)  1.372p         1.344p

 

Total return performance to 30 April 2025 (including dividends reinvested and
excluding transaction costs)

 

                      6 months  1 year  3 years  5 years  10 years

                      %         %       %        %         %
 NAV(1)               -4.0      -1.1    14.8     49.3     129.2
 Share price(3)       0.1       0.0     11.5     35.7     118.1
 FTSE World Index(4)  -2.6      5.3     29.5     83.9     144.4

 

 

1 Net asset value total return per share with income reinvested and with debt
at fair value, see Note 6 in the Notes to the Condensed Financial Statements

2 The first interim dividend for 2025 was paid on 30 May 2025; the second
interim dividend has been declared and will be paid on 29 August 2025

3 Share price total return using mid-market closing price

4 For 10 years, the benchmark is a composite of the FTSE World Index and the
FTSE All-Share Index

 

 

Sources: Janus Henderson, Morningstar Direct and LSEG Datastream

INTERIM MANAGEMENT REPORT

 

CHAIR'S STATEMENT

 

Dear shareholder,

 

Performance

The first half of the year has been dominated by the impact on markets of
Donald Trump's election. The positive market enthusiasm which accompanied
Trump's victory in November had evaporated by early April when he announced a
swathe of much higher-than-expected tariffs on all US trading partners. My
last statement highlighted that the greatest uncertainty this year would be
the outcome of US tariffs. Share prices fell from their peak in February, as
the new administration started discussing plans for trade tariffs on imported
goods to the US market. Markets do not like uncertainty and investors sold
both bonds and equities, forcing down the value of the US dollar. Performance
was positive in Europe and Japan where governments are finally tackling slower
growth with more reforms and increased spending plans.

 

Your Company has delivered a net asset value total return over the six months
ended 30 April 2025 of -4.0% (six months to 30 April 2024: +17.5%) and a share
price total return of +0.1% (2024: +21.5%), compared with the FTSE World Index
benchmark total return of -2.6% (2024: +16.6%) over the same period. Most of
the underperformance in the portfolio happened in November, following a sharp
rise in US stocks associated with the new administration's policies. Over the
remainder of the period, the portfolio outperformed its benchmark, and this
outperformance continued through May. The Fund Manager discusses the key
drivers of performance in his report.

 

Revenue and financial statements

Our net revenue for the six months was £12.6 million (2024: £15.9 million),
equivalent to 1.16p per share (2024: 1.31p). We expected the reduction in
revenue as a result of increasing investment into growth stocks. Companies in
the Technology and Healthcare sectors have significant growth opportunities
and are prioritising investment spending over dividends. The expectation is
that profits will accelerate over time and ultimately lead to higher
dividends. In the short term, drawing down on our revenue reserves will allow
maintenance of a progressive dividend.

 

A first interim dividend of 0.686p per share (2024: 0.672p) was paid on 30 May
2025. The Board has declared a second interim dividend of 0.686p (2024:
0.672p) per share, an increase of 2.1%, which will be payable on 29 August
2025 to shareholders on the register on 25 July 2025.

 

The Board's current expectation is that the dividend for the full year will be
at least 2% above the total dividend paid in 2024. This modest forecast
reflects the current uncertainty in the market's forecasts for corporate
profits and therefore dividends. However, it will continue to deliver the
Company's progressive dividend policy of successive annual dividend growth
which it has achieved every year over the past 58 years.

 

Discount management

The Company's share price has continued to trade at a discount to its net
asset value and we have taken advantage of this opportunity to buy back shares
from the market. This activity is beneficial to ongoing shareholders, as
shares are only purchased when they are trading at a discount, thereby
enhancing shareholder value.

 

A total of 82,700,048 shares were bought back at an average discount of 10.2%
to the net asset value in the six months ended 30 April 2025 (2024: 49,748,991
shares bought back at an average discount of 12.3%) for a total consideration
of £97.1 million (2024: £53.4 million). The discount at 30 April 2025 was
9.8% (2024: 10.6%).

 

Outlook

The hope is that the US will agree a reasonable level of tariffs with key
trading partners. However, if the ongoing uncertainty extends through the
summer, this will impact growth and ultimately profits. It would be premature
to write off the US stock market at this point, given further reforms could
well support growth in the economy.

 

 

Simon Miller

Chair

24 June 2025

 

 

FUND MANAGER'S
REPORT

 

Market Review

The six months to the end of April 2025 was a particularly volatile period for
both bond and share prices, encompassing the presidential win by Donald Trump
and the subsequent slew of new presidential orders. The US stock market rose
by 5% in November, on the back of optimism that Trump would be business
friendly, delivering tax cuts and policies to promote growth. This honeymoon
period did not last long into the new year before worries started to arise.
Markets peaked in February, then fell sharply on concerns about trade tariffs
disrupting corporates and creating price inflation for consumers. The
unveiling of specific country tariff rates on Liberation Day, in early April,
shocked investors and was compounded by the face-off with China with their
tariffs rising above 100%. Since then, markets have recaptured much of the
fall, with hopes that pragmatism will prevail.

 

The US has called on other nations to raise their defence spending, which has
spurred Germany to significantly raise investment spending on defence and
energy. The promise of higher spending in Europe has supported their stock
markets, although the real effect on GDP growth will be a few years into the
future. Japan also performed well, as the currency strengthened and interest
rates increased, supporting large sectors of the market like banks.

 

The policy uncertainty has driven a fear of recession, but corporate results
delivered broadly in line with forecasts. While estimates for this year's
growth have been reduced, most commentators are still predicting economic and
corporate profit growth for all regions.

 

Performance

The portfolio underperformed the benchmark during November due to lower
exposure to the US market than the index and underperformance of stock
selection in the US market. Since November, the asset allocation has been more
favourable and stock selection has improved, although we were unable to make
up all the underperformance. The best regions in absolute terms have been
Europe and Japan: both rose by 5.5% in Sterling terms during the period. The
Japanese stocks outperformed their benchmark index by 3%, driven predominantly
by financials but Sony also put in a good performance, driven by high
expectations on the gaming side of the business.

 

Financials generally were the largest positive contributor to relative
performance. Banks have performed well as earnings are supported by interest
rate hedging and expanding loan books, while cost pressure is easing through
new digital offerings. Technology also performed well, driven by ongoing AI
optimism although performance faded in the technology hardware sector on
worries about tariffs. Healthcare and retail sectors held back performance.
Valuations in the healthcare sector fell on concerns about pricing, tariffs
and drug patent expiries. In the consumer sectors, rising prices have caused
shoppers to prioritise their spending and to favour better value offerings,
hitting margins.

 

Portfolio

The portfolio's allocation to the US market was increased following the US
presidential election as the market friendly Republican party claimed the
victory. Even with the allocation to the US market peaking at 63%, it remained
below the benchmark's US allocation. Over the remaining months we have used
the US market as a source of cash to fund the share buybacks, reducing the
allocation to 60% by the period end. Gearing has been maintained at around 5%
during the period, as we made sure that we were positioned for a bounce in
markets. The portfolio is overweight Europe and Japan relative to the
benchmark, as we feel valuations are more appealing, combined with less
exposure to the challenges of rising trade tariffs.

 

Outlook

It is notable that share prices have recovered most of their fall this year
despite any real certainty on trade negotiations between the US and their
trading partners. Bringing manufacturing back to the US is likely to be
impractical in some key sectors like textiles and is certain to depress
margins in sectors like pharmaceuticals and technology. If tariffs end up in
the 10% to 20% range, then the market is likely to move its focus to the more
business friendly policies in the US, such as tax reforms and deregulation.
Elsewhere in the world, economic growth is recovering from last year's
slowdown and interest rate cuts are supporting easier monetary conditions.
Valuations are lower than the US and may improve as confidence in growth
increases.

 

 

Alex Crooke

Fund Manager

24 June 2025

 

 

 MANAGING OUR RISKS

 The principal and emerging risks and uncertainties associated with the
 Company's business are divided into the following main areas:

 ·              Investment Activity and Performance Risks

 ·              Portfolio and Market Risks

 ·              Tax, Legal, Regulatory and Governance Risks

 ·              Financial Risks

 ·              Operational and Cyber Risks

 ·              Risks associated with Climate Change

 Information on these risks and uncertainties and how they are managed are
 given in the Annual Report for the year ended 31 October 2024. Following a
 recent review, the Board has amended Tax, Legal and Regulatory Risk to include
 Governance. All other principal and emerging risks at the year-end remain and
 are as applicable to the remaining six months of the financial year as they
 were to the six months under review.

 DIRECTORS' RESPONSIBILITY STATEMENT

 The Directors (listed in note 14) confirm that, to the best of their
 knowledge:

 (a)  the unaudited condensed set of financial statements has been prepared in
      accordance with IAS 34 - Interim Financial Reporting ('IAS 34') and gives a
      true and fair view of the assets, liabilities, financial position and profit
      or loss of the Company as required by Disclosure Guidance and Transparency
      Rule 4.2.4R;

 (b)  the interim management report includes a fair review of the information
      required by Disclosure Guidance and Transparency Rule 4.2.7R (indication of
      important events during the first six months and description of principal
      risks and uncertainties for the remaining six months of the year); and

 (c)  the interim management report includes a fair review of the information
      required by Disclosure Guidance and Transparency Rule 4.2.8R (disclosure of
      related party transactions that have taken place in the first six months of
      the current financial year and that have materially affected the financial
      position or the performance of the Company during the period; and any changes
      in related party transactions described in the latest annual report that could
      have an impact in the first six months of the current financial year).

 On behalf of the Board

 Simon Miller

 Chair

 24 June 2025

 

 

 

For further information contact:

 

 Alex Crooke                        Simon Miller

 Fund Manager                       Chair

 The Bankers Investment Trust PLC   The Bankers Investment Trust PLC

 Telephone: 020 7818 4447           Telephone: 020 7818 1818

 Dan Howe                           Harriet Hall

 Head of Investment Trusts          PR Director, Investment Trusts

 Janus Henderson Investors          Janus Henderson Investors

 Telephone: 020 7818 1818           Telephone: 020 7818 2636

 

CONDENSED STATEMENT OF COMPREHENSIVE INCOME

                                                                          (Unaudited)                                                  (Unaudited)                                                  (Audited)

                                                                          Half-year ended                                              Half-year ended                                              Year ended

                                                                          30 April 2025                                                30 April 2024                                                31 October 2024
                                                                          Revenue return £'000   Capital return £'000                  Revenue return £'000   Capital return £'000                  Revenue return £'000   Capital return £'000

                                                                                                                        Total £'000                                                  Total £'000                                                  Total

                                                                                                                                                                                                                                                  £'000
 (Losses)/gains on investments held at fair value through profit or loss  -                      (70,740)               (70,740)       -                      177,057                177,057        -                      205,394                205,394
 Investment income                                                        16,080                 -                      16,080         19,107                 -                      19,107         37,652                 -                      37,652
 Other operating income                                                   536                    -                      536            567                    -                      567            1,003                  -                      1,003
                                                                          ---------              -----------            ---------      ---------              -----------            ---------      -----------            -----------            -----------
 Gross revenue and capital (losses)/gains                                 16,616                 (70,740)               (54,124)       19,674                 177,057                196,731        38,655                 205,394                244,049
                                                                          ----------             ------------           -----------    ----------             -----------            -----------    -----------            -----------            -----------
 Expenses
 Management fees (note 2)                                                 (900)                  (2,099)                (2,999)        (910)                  (2,123)                (3,033)        (1,856)                (4,334)                (6,190)
 Other expenses                                                           (777)                  -                      (777)          (642)                  -                      (642)          (1,329)                -                      (1,329)
                                                                          ---------              -----------            ---------      ---------              -----------            ---------      ---------              ---------              ---------
 Profit/(loss) before finance costs and taxation                          14,939                 (72,839)               (57,900)       18,122                 174,934                193,056        35,470                 201,060                236,530
 Finance costs                                                            (491)                  (1,145)                (1,636)        (519)                  (1,151)                (1,670)        (998)                  (2,329)                (3,327)
                                                                          ---------              -----------            ---------      ---------              -----------            ---------      ---------              -----------            -----------
 Profit/(loss) before taxation                                            14,448                 (73,984)               (59,536)       17,603                 173,783                191,386        34,472                 198,731                233,203
                                                                          ---------              ----------             ---------      ---------              ----------             ---------      ---------              ----------             ---------
 Taxation                                                                 (1,859)                (133)                  (1,992)        (1,662)                (59)                   (1,721)        (3,194)                (59)                   (3,253)
                                                                          ---------              -----------            ---------      ---------              -----------            ---------      ---------              ----------             ---------
 Profit/(loss) for the period                                             12,589                 (74,117)               (61,528)       15,941                 173,724                189,665        31,278                 198,672                229,950
                                                                          =====                  ======                 ======         =====                  ======                 ======         ======                 ======                 ======
 Earnings/(loss) per ordinary share (note 3)                              1.16p                  (6.83p)                (5.67p)        1.31p                  14.31p                 15.62p         2.63p                  16.70p                 19.33p
                                                                          =====                  ======                 ======         =====                  ======                 ======         ======                 ======                 ======

 

 

The total columns of this statement represent the Statement of Comprehensive
Income, prepared in accordance with UK adopted international accounting
standards. The revenue return and capital return columns are supplementary to
this and are prepared under guidance published by the Association of
Investment Companies.

 

All income is attributable to the equity shareholders of The Bankers
Investment Trust PLC.

 

The accompanying condensed notes are an integral part of the financial
statements.

 

 

 

CONDENSED STATEMENT OF CHANGES IN EQUITY
 
 
 
 

                                                          Called up                 Share premium        Capital redemption      Other capital reserves

                                                         share capital             account               reserve                 £'000                       Revenue reserve

 Half-year ended 30 April 2025 (Unaudited)               £'000                     £'000                 £'000                                               £'000                 Total

                                                                                                                                                                                   £'000
 Total equity at 1 November 2024                         32,878                    159,797               12,489                  1,186,189                   42,793                1,434,146
 Total comprehensive income:
 - Loss for the period                                   -                         -                     -                       (74,117)                    12,589                (61,528)
 Transactions with owners, recorded

 directly to equity:
 - Buy-back of shares to treasury (note 5)               -                         -                     -                       (97,117)                    -                     (97,117)
 - Ordinary dividends paid (note 11)                     -                         -                     -                       -                           (15,203)              (15,203)
                                                         ----------                ----------            ----------              -------------               ----------            --------------
 Total equity at                                         32,878                    159,797               12,489                  1,014,955                   40,179                1,260,298

30 April 2025
                                                         ======                    ======                ======                  ========                    ======                ========

                                                          Called up      Share               Capital redemption      Other capital

                                                         share capital   premium             reserve                 reserves                  Revenue reserve

 Half-year ended 30 April 2024 (Unaudited)               £'000           account             £'000                   £'000                     £'000                    Total

                                                                         £'000                                                                                          £'000
 Total equity at 1 November 2023                         32,878          159,797             12,489                  1,084,848                 43,511                   1,333,523
 Total comprehensive income:
 - Profit for the period                                 -               -                   -                       173,724                   15,941                   189,665
 Transactions with owners, recorded

 directly to equity:
 - Buy-back of shares to treasury (note 5)               -               -                   -                       (53,389)                  -                        (53,389)
 - Ordinary dividends paid (note 11)                     -               -                   -                       -                         (16,205)                 (16,205)
                                                         ----------      ----------          ----------              -------------             ----------               --------------
 Total equity at 30 April 2024                           32,878          159,797             12,489                  1,205,183                 43,247                   1,453,594
                                                         ======          ======              ======                  ========                  ======                   ========

                                                          Called up       Share premium      Capital redemption      Other capital

                                                         share capital   account             reserve £'000           reserves                  Revenue reserve          Total

 Year ended 31 October 2024 (Audited)                    £'000           £'000                                       £'000                     £'000                    £'000
 Total equity at 1 November 2023                         32,878          159,797             12,489                  1,084,848                 43,511                   1,333,523
 Total comprehensive income:
  - Profit for the year                                  -               -                   -                       198,672                   31,278                   229,950
 Transactions with owners, recorded directly to equity:
 - Buy-back of shares to treasury (note 5)               -               -                   -                       (97,331)                                           (97,331)
 - Ordinary dividends paid (note 11)                     -               -                   -                       -                         (31,996)                 (31,996)
                                                         ----------      ----------          -----------             -------------             ----------               -------------
 Total equity at 31 October 2024                         32,878          159,797             12,489                  1,186,189                 42,793                   1,434,146
                                                         ======          ======              ======                  ========                  ======                   ========

 

The accompanying condensed notes are an integral part of the financial
statements.

CONDENSED STATEMENT OF FINANCIAL POSITION

                                                                 (Unaudited)      (Unaudited)      (Audited)

                                                                 As at 30 April   As at 30 April   As at 31 October

                                                                 2025             2024             2024

                                                                 £'000            £'000            £'000

 Non-current assets
 Investments held at fair value through profit or loss           1,320,427        1,530,994        1,455,333
                                                                 -------------    -------------    -------------

 Current assets
 Investments held at fair value through profit or loss (note 4)  23,962           21,509           33,549
 Other receivables                                               4,658            7,128            4,646
 Cash and cash equivalents                                       39,175           28,726           66,689
                                                                 --------------   --------------   --------------
                                                                 67,795           57,363           104,884
                                                                 --------------   --------------   --------------
 Total assets                                                    1,388,222        1,588,357        1,560,217
                                                                 --------------   --------------   --------------
 Current liabilities
 Other payables                                                  (3,867)          (10,604)         (2,315)
                                                                 --------------   --------------   --------------
                                                                 (3,867)          (10,604)         (2,315)
                                                                 --------------   --------------   --------------
 Total assets less current liabilities                           1,384,355        1,577,753        1,557,902
                                                                 --------------   --------------   --------------
 Non-current liabilities
 Unsecured loan notes                                            (124,057)        (124,159)        (123,756)
                                                                 --------------   --------------   --------------
 Net assets                                                      1,260,298        1,453,594        1,434,146
                                                                 ========         ========         ========

 Equity attributable to equity shareholders
 Share capital (note 5)                                          32,878           32,878           32,878
 Share premium account                                           159,797          159,797          159,797
 Capital redemption reserve                                      12,489           12,489           12,489
 Retained earnings:
   Other capital reserves                                        1,014,955        1,205,183        1,186,189
   Revenue reserve                                               40,179           43,247           42,793
                                                                 --------------   --------------   --------------
 Total equity                                                    1,260,298        1,453,594        1,434,146
                                                                 ========         ========         ========
 Net asset value per ordinary share (note 6)                     118.5p           122.7p           125.2p
                                                                 ======           ======           ======

 

The accompanying condensed notes are an integral part of the financial
statements.

 

 

 

CONDENSED CASH FLOW STATEMENT

                                                                             (Unaudited)       (Unaudited)       Restated(1) (Audited)

                                                                             Half-year ended   Half-year ended   Year ended

                                                                              30 April         30 April          31 October

 Reconciliation of profit before taxation to net cash flow                   2025              2024               2024

 from operating activities                                                   £'000             £'000             £'000
 Operating activities
 (Loss)/profit before taxation                                               (59,536)          191,386           233,203
 Less: loss/(gain) on investments held at fair value through profit or loss  70,740            (177,057)         (205,394)
 Purchases of investments                                                    (458,000)         (353,778)         (1,013,738)
 Sales of investments                                                        524,303           428,187           1,191,430
 Purchases of current asset investments                                      (93,533)          (49,907)          (117,393)
 Sales of current asset investments                                          103,120           41,514            96,959
 Increase/(decrease) in securities purchased for future settlement           632               13,540            (13,721)
 (Increase)/decrease in securities sold for future settlement                -                 (6,271)           13,559
 (Increase)/decrease in other receivables                                    (30)              (32)              32
 Increase/(decrease) in other payables                                       73                (104)             (94)
 Decrease/(increase) in accrued income                                       65                (1,651)           502
 Add back interest payable ('finance costs')                                 1,636             1,670             3,327
                                                                             ------------      ------------      ------------
 Net cash inflow from operating activities                                   89,470            87,497            188,672

 before interest and taxation
 Interest paid                                                               (1,664)           (2,438)           (3,359)
 Taxation paid                                                               (2,038)           (1,706)           (2,932)
                                                                             ------------      ------------      ------------
 Net cash inflow from operating activities                                   85,768            83,353            182,381
                                                                             =======           =======           =======

 Financing activities
 Equity dividends paid                                                       (15,203)          (16,205)          (31,996)
 Share buy-backs                                                             (96,244)          (53,389)          (98,207)
                                                                             ------------      ------------      ------------
 Net cash outflow from financing activities                                  (111,447)         (69,594)          (130,203)
                                                                             =======           =======           =======

 (Decrease)/increase in cash                                                 (25,679)          13,759            52,178
 Cash and cash equivalents at the start of the period                        66,689            14,525            14,525
 Exchange movements                                                          (1,835)           442               (14)
                                                                             -----------       -----------       ------------
 Cash and cash equivalents at the end of the period                          39,175            28,726            66,689
                                                                             =======           =======           =======

 

(1)Prior year comparatives have been restated as explained further in note 1.

 

The accompanying condensed notes are an integral part of the financial
statements.

 

 

 

NOTES TO THE CONDENSED FINANCIAL STATEMENTS:

 

 1.  Accounting policies
     The Bankers Investment Trust PLC ('the Company') is a company incorporated and
     domiciled in the United Kingdom under the Companies Act 2006.

     These condensed financial statements comprise the unaudited results of the
     Company for the half-year ended 30 April 2025. They have been prepared on a
     going concern basis and in accordance with UK adopted international accounting
     standards and with the Statement of Recommended Practice for Investment Trusts
     ('SORP') dated July 2022, where the SORP is consistent with the requirements
     of UK adopted international accounting standards.

     For the period under review, the Company's accounting policies have not varied
     in any material way from those described in the Annual Report for the year
     ended 31 October 2024.

     These financial statements have not been either audited or reviewed by the
     Company's Auditor.

     Restatement of Cash Flow Statement

     Following publication of the annual financial statements for the year ended 31
     October 2024, an error was identified in the cash flow statement whereby the
     cash balance did not agree to the Statement of Financial Position. This error
     was primarily due to an omission of a line item in the cash flow statement
     relating to the movement in 'securities sold for future settlement' and
     additionally a classification error in relation to 'interest paid'. These
     matters resulted in the value of the 'Cash and cash equivalents at the end of
     the year' being incorrect. The error did not impact the Statement of
     Comprehensive Income, Statement of Changes in Equity or the Statement of
     Financial Position, where the correct cash position was presented, nor did it
     impact earnings per share or the net asset value per share.

     The comparative figures in the Cash Flow Statement for the year ended 31
     October 2024 have therefore been restated to correct these errors and the
     following corrections have been made, which include corrections to a number of
     the sub-totals within the statement:

Cash flow line item                                                     As previously reported  As restated  Impact on line

                                         £'000                   £'000        £'000
     (Increase)/decrease in securities sold for future settlement            -                       13,559       13,559

     Net cash inflow from operating activities before interest and taxation  175,113                 188,672      13,559
     (sub-total)

     Interest paid                                                           (4,506)                 (3,359)      1,147

     Net cash flow from operating activities (sub-total)                     167,675                 182,381      14,706

     (Decrease)/increase in cash (sub-total)                                 37,472                  52,178       14,706

     Cash and cash equivalents                                               51,983                  66,689       14,706

 2.  Management fees
                            (Unaudited)                                  (Unaudited)                                                         (Audited)
                            Half-year ended                              Half-year ended                                                     Year ended

                            30 April 2025                                30 April 2024                                                       31 October 2024
                            Revenue return  Capital return  Total        Revenue                   Capital return  Total                     Revenue return  Capital return  Total

                            £'000           £'000           £'000        return                    £'000           £'000                     £'000           £'000           £'000

                                                                         £'000
     Investment management  900             2,099           2,999        910                       2,123           3,033                     1,856           4,334           6,190
                            =====           =====           =====        =====                     =====           =====                     =====           =====           =====

 3.  Earnings per ordinary share
     The earnings per ordinary share figure is based on the net loss for the
     half-year of £61,528,000 (30 April 2024: net profit of £189,665,000; 31
     October 2024: net profit of £229,950,000) and on 1,085,471,866 (30 April
     2024: 1,214,507,013; 31 October 2024: 1,189,599,929) ordinary shares, being
     the weighted average number of ordinary shares in issue excluding treasury
     shares during the period.

     The return per share detailed above can be further analysed between revenue
     and capital, as below.

                                                                                      (Unaudited)                               (Unaudited)                  (Audited)

                                                                                      Half-year ended                            Half-year ended             Year ended

                                                                                      30 April 2025                             30 April 2024                31 October 2024

                                                                                      £'000                                     £'000                        £'000
     Revenue profit                                                                   12,589                                    15,941                       31,278
     Capital (loss)/profit                                                            (74,117)                                  173,724                      198,672
                                                                                      ------------                              ------------                 -----------
     Total (loss)/profit                                                              (61,528)                                  189,665                      229,950
                                                                                      =======                                   =======                      =======
     Weighted average number of ordinary shares                                       1,085,471,866                             1,214,507,013                1,189,599,929

     in issue during each period

     Revenue earnings per ordinary share                                              1.16p                                     1.31p                        2.63p
     Capital (loss)/earnings per ordinary share                                       (6.83p)                                   14.31p                       16.70p
                                                                                      ------------                              ------------                 -----------
     Total (loss)/earnings per ordinary share                                         (5.67p)                                   15.62p                       19.33p
                                                                                      =======                                   =======                      =======

 

2.

Management fees

 

 

(Unaudited)

(Unaudited)

(Audited)

 

 

Half-year ended

30 April 2025

Half-year ended

30 April 2024

Year ended

31 October 2024

 

 

Revenue return

£'000

Capital return

£'000

Total

£'000

Revenue

return

£'000

Capital return

£'000

Total

£'000

Revenue return

£'000

Capital return

£'000

Total

£'000

Investment management

900

2,099

2,999

910

2,123

3,033

1,856

4,334

6,190

=====

=====

=====

=====

=====

=====

=====

=====

=====

 

 

 

3.

Earnings per ordinary share

 

The earnings per ordinary share figure is based on the net loss for the
half-year of £61,528,000 (30 April 2024: net profit of £189,665,000; 31
October 2024: net profit of £229,950,000) and on 1,085,471,866 (30 April
2024: 1,214,507,013; 31 October 2024: 1,189,599,929) ordinary shares, being
the weighted average number of ordinary shares in issue excluding treasury
shares during the period.

 

 

The return per share detailed above can be further analysed between revenue
and capital, as below.

 

 

(Unaudited)

Half-year ended

30 April 2025

£'000

(Unaudited)

 Half-year ended

30 April 2024

£'000

(Audited)

Year ended

31 October 2024

£'000

Revenue profit

12,589

15,941

31,278

Capital (loss)/profit

(74,117)

173,724

198,672

------------

------------

-----------

Total (loss)/profit

(61,528)

189,665

229,950

=======

=======

=======

Weighted average number of ordinary shares

in issue during each period

1,085,471,866

1,214,507,013

1,189,599,929

 

Revenue earnings per ordinary share

1.16p

1.31p

2.63p

Capital (loss)/earnings per ordinary share

(6.83p)

14.31p

16.70p

------------

------------

-----------

Total (loss)/earnings per ordinary share

(5.67p)

15.62p

19.33p

=======

=======

=======

 

 4.  Current asset investment

     The Company has a holding in the Deutsche Bank Global Liquidity Series Fund, a
     money market fund which is viewed as a readily disposable store of value and
     which is used to invest cash balances that would otherwise be placed on
     short-term deposit. At 30 April 2025 this holding had a value of £23,962,000
     (30 April 2024: £21,509,000; 31 October 2024: £33,549,000).

 5.  Share capital
     At 30 April 2025 there were 1,315,102,830 ordinary shares of 2.5p each in
     issue of which 251,912,008 were held in treasury (with no voting rights) (30
     April 2024: 1,315,102,830 of which 130,619,544 were held in treasury; 31
     October 2024: 1,315,102,830 of which 169,211,960 were held in treasury).
     During the half-year ended 30 April 2025, 82,700,048 shares were bought back
     into treasury at a total cost of £97,117,000 (half year to 30 April 2024:
     49,748,991 shares were bought back into treasury at a total cost of
     £53,389,000; year to 31 October 2024: 88,341,407 shares were bought back in
     to treasury for a total cost of £97,331,000). Since the period end to 24 June
     2025, the Company has bought back 16,648,525 shares for treasury for a total
     cost of £19,467,000.

 6.  Net asset value per ordinary share
     The net asset value per ordinary share is based on the net assets attributable
     to equity shareholders of £1,260,298,000 (30 April 2024: £1,453,594,000; 31
     October 2024: £1,434,146,000) and on 1,063,190,822 (30 April 2024:
     1,184,483,286; 31 October 2024: 1,145,890,870) ordinary shares, being the
     number of ordinary shares in issue with voting rights at the period end.

     The following table reconciles from the NAV with debt at par to the NAV with
     debt at fair value.

     Net asset value ("NAV") with debt at par and at fair value

                                                                                                                   30 April 2025                   30 April 2024                   31 Oct 2024
                                                                                                                   £'000                           £'000                           £'000
     NAV with debt at par (A)                                                                                               1,260,298                       1,453,594                       1,434,146
     Add back par value of loan notes                                                                              124,057                         124,159                         123,756
     Less fair value of loan notes                                                                                 (92,324)                        (91,757)                        (92,618)
     NAV with debt at fair value (B)                                                                               1,292,031                       1,485,996                       1,465,284

     Ordinary shares in issue (C)                                                                                  1,063,190,822                   1,184,483,286                   1,145,890,870

     NAV per ordinary share with debt at par                                                                       118.5                           122.7                           125.2

     (A/C x 100) (pence)
     NAV per ordinary share with debt at fair value (B/C x 100) (pence)                                            121.5                           125.5                           127.9

 7.  Related party transactions
     The Company's transactions with related parties during the period were with
     its Directors and Janus Henderson.  There have been no material transactions
     between the Company and its Directors during the period other than the amounts
     paid to them in respect of Directors' remuneration for which there were no
     outstanding amounts payable at the period end.

     In relation to the provision of services by Janus Henderson, other than fees
     payable by the Company in the ordinary course of business and the provision of
     marketing services, there have been no transactions with Janus Henderson
     affecting the financial position or performance of the Company during the
     period under review.

 8.  Financial instruments
     At the period end the carrying value of financial assets approximates their
     fair value.

     Financial instruments carried at fair value

     Fair value hierarchy

     The unsecured loan notes are valued at par in the Statement of Financial
     Position.

     The fair value of the loan notes at 30 April 2025 has been estimated to be
     £92,324,000 (30 April 2024: £91,757,000; 31 October 2024: £92,618,000) and
     is categorised as level 3 in the fair value hierarchy as described below. This
     has been reflected in the daily NAV announcements since January 2024.
     Previously the unsecured loan notes were valued at amortised cost in the fair
     value NAV.

     The following table analyses recurring fair value measurements for financial
     assets. These fair value measurements are categorised into different levels in
     the fair value hierarchy based on the inputs to valuation techniques used.

     Financial assets at fair value through profit or loss at 30 April 2025    Level 1                                             Level 2                         Level 3                         Total
     (Unaudited)

                                                                               £'000                                               £'000                           £'000                           £'000
     Investments including derivatives:
     - Equity investments                                                      1,320,427                                           -                               -                               1,320,427
     - Fixed interest investments                                              -                                                   -                               -                               -
     - Current asset investments                                               23,962                                              -                               -                               23,962
                                                                               --------------                                      ---------                       --------                        --------------
     Total financial assets carried at fair value                              1,344,389                                           -                               -                               1,344,389
                                                                               ========                                            =====                           =====                           ========

     Financial assets at fair value through profit or loss at 30 April 2024    Level 1                                             Level 2                         Level 3                         Total
     (Unaudited)

                                                                               £'000                                               £'000                           £'000                           £'000
     Investments including derivatives:
     - Equity investments                                                      1,530,994                                           -                               -                               1,530,994
     - Fixed interest investments                                              -                                                   -                               -                               -
     - Current asset investments                                               21,509                                              -                               -                               21,509
                                                                               --------------                                      ---------                       --------                        --------------
     Total financial assets carried at fair value                              1,552,503                                           -                               -                               1,552,503
                                                                               ========                                            =====                           ====                            ========

     Financial assets at fair value through profit or loss at 31 October 2024  Level 1                                             Level 2                         Level 3                         Total
     (Unaudited)

                                                                               £'000                                               £'000                           £'000                           £'000
     Investments including derivatives:
     - Equity investments                                                      1,455,333                                           -                               -                               1,455,333
     - Fixed interest investments                                              -                                                   -                               -                               -
     - Current asset investments                                               33,549                                              -                               -                               33,549
                                                                               --------------                                      ---------                       --------                        --------------
     Total financial assets carried at fair value                              1,488,882                                           -                               -                               1,488,882
                                                                               ========                                            =====                           ====                            ========

 

 9.        Reconciliation of liabilities arising from financing activities
                                                          Non-cash changes
                                                          At

                                                          1 November             Cash                Amortisation                    Foreign                At 30 April

                                                          2024                   flows                of issue costs                 exchange               2025

                                                          £'000                  £'000               £'000                           £'000                  £'000
            Financing activities
            Financing liabilities                         123,756                -                   10                              291                    124,057
           Closing liabilities from financing activities  -----------            -----------         -----------                     -----------            -----------

                                                          123,756                -                   10                              291                    124,057

                                                          ======                 ======              ======                          ======                 ======
                                                          Non-cash changes
                                                          At                     Cash                                                Foreign                At 30 April

                                                          1 November             flows               Amortisation                    exchange               2024

                                                          2023                   £'000                of issue costs                 £'000                  £'000

                                                          £'000                                      £'000
            Financing activities
            Financing liabilities                         124,900                -                   14                              (755)                  124,159
           Closing liabilities from financing activities  ----------             ---------           ---------                       ---------              ----------

                                                          124,900                -                   14                              (755)                  124,159

                                                          ======                 ======              ======                          ======                 ======

                                                          Non-cash changes
                                                          At           Cash                                                          Foreign      At 31 October

                                                          1 November    flows                                  Amortisation          exchange     2024

                                                          2023         £'000                                    of issue costs       £'000        £'000

                                                          £'000                                                £'000
            Financing activities
            Financing liabilities                         124,900      -                                       26                    (1,170)      123,756
           Closing liabilities from financing activities  -----------  ---------                               -----------           -----------  -----------

                                                          124,900      -                                       26                    (1,170)      123,756

                                                          ======       ======                                  ======                ======       ======

 10.       Going concern
           In assessing the Company's going concern, the Directors have considered among
           other things, cash flow forecasts, a review of covenant compliance including
           the headroom above the most restrictive covenants and an assessment of the
           liquidity of the portfolio and the impact of the war in Ukraine and Israel and
           changes in the international political landscape. The assets of the Company
           consist mainly of securities that are listed and readily realisable. Thus,
           after making due enquiry, the Directors believe that the Company has adequate
           financial resources to meet its financial obligations, including the repayment
           of any borrowings, and to continue in operational existence for at least 12
           months from the date of approval of the financial statements. Accordingly, the
           Directors continue to adopt the going concern basis in preparing the financial
           statements.

 11.       Dividends
           A first interim dividend of 0.686p (2024: 0.672p) per ordinary share, was paid
           on 30 May 2025 to shareholders registered on 25 April 2025. The shares were
           quoted ex-dividend on 24 April 2025. Based on the number of ordinary shares in
           issue at 25 April 2025 (excluding shares held in treasury) of 1,064,854,738
           the cost of this dividend was £7,305,000.

           The Directors have declared a second interim dividend of 0.686p (2024: 0.672p)
           per ordinary share which will be payable on 29 August 2025 to shareholders on
           the register on 25 July 2025. The shares will be quoted ex-dividend on 24 July
           2025. Based on the number of shares in issue, excluding shares held in
           treasury, at 24 June 2025 of 1,046,542,297 the cost of this dividend will be
           £7,179,000.

 12.       Comparative information
           The financial information contained in this half-year report does not
           constitute statutory accounts as defined in Section 434 of the Companies Act
           2006. The financial information for the half-years ended 30 April 2025 and
           2024 have not been audited or reviewed by the Auditor.

           The figures and financial information for the year ended 31 October 2024 have
           been extracted from the latest published financial statements of the Company.
           These financial statements have been delivered to the Registrar of Companies
           and included the report of the Auditor which was unqualified and did not
           contain a statement under either section 498(2) or 498(3) of the Companies Act
           2006. A glossary of terms and details of alternative performance measures can
           be found in the Annual Report for the year ended 31 October 2024.

 13.       Half-year report
           The half-year report will be available on the Company's website
           (www.bankersinvestmenttrust.com) or in hard copy from the Company's registered
           office. An abbreviated version of this half-year report, the 'Update', will be
           circulated to shareholders in early July 2025.

 14.       General information
           Company status

           The Company is a UK domiciled investment trust company.

           London Stock Exchange Daily Official List (SEDOL): BN4NDR3 / ISIN number:
           GB00BN4NDR39

           London Stock Exchange (TIDM) Code: BNKR

           New Zealand Stock Exchange Code: BIT

           Global Intermediary Identification Number (GIIN): L5YVFP.99999.SL.826

           Legal Entity Identifier (LEI): 213800B9YWXL3X1VMZ69

           Registered Office

           201 Bishopsgate, London EC2M 3AE

           Company Registration Number

           UK:  00026351

           NZ:  645360

           Directors

           The Directors of the Company are Simon Miller (Chair), Richard West (Senior
           Independent Director), Ankush Nandra (Audit & Risk Assurance Committee
           Chair), Hannah Philp (Marketing Committee Chair) and Charlotte Valeur.

           Corporate Secretary

           Janus Henderson Secretarial Services UK Limited.

           Website

           Details of the Company's share price and net asset value, together with
           general information about the Company, monthly factsheets and data, copies of
           announcements, reports and details of general meetings can be found at
           www.bankersinvestmenttrust.com (http://www.bankersinvestmenttrust.com) .

 

50 Largest Investments

At 30 April 2025

 Rank          Rank          Company                      Country      Valuation                                                           Purchases                                                   Sales proceeds  Appreciation/     Valuation

31 Oct

(depreciation)
30 Apr
 30 Apr 2025   31 Oct 2024
                                                                   £'000                                                       £'000

                                                                       2024                                                                                                                                            £'000            2025

                                                                       £'000                                                                                                                                                            £'000
 1             1             Microsoft                    US           65,307                                                                                16,451                                    (9,586)         (6,377)                             65,795
 2             5             Alphabet                     US           27,066                                                                                19,084                                    (1,683)         (5,821)                             38,646
 3             4             Broadcom                     US           28,032                                                                                  9,158                                   (1,463)         2,867                               38,594
 4             3             Amazon                       US           35,436                                                                                10,568                                    (6,413)         (2,614)                             36,977
 5             2             Apple                        US                                 46,595                                                          12,592                                    (18,723)        (4,842)                             35,622
 6             11            Meta                         US                                 23,260                                                          12,931                                    (3,585)         (2,946)                             29,660
 7             29            Eli Lilly                    US           17,064                                                                                10,956                                    (1,080)         1,234                               28,174
 8             6             KLA Corp                     US           26,961                                                                                  5,667                                   (5,792)         522                                 27,358
 9             8             Visa                         US           25,759                                                                                  6,978                                   (9,773)         3,869                               26,833
 10            10            American Express             US           23,729                                                                                  6,701                                   (2,086)         (2,227)                             26,117
 11            40            Philip Morris International  US           14,707                                                                                  7,396                                   (1,316)         5,243                               26,030
 12            21            Morgan Stanley               US           19,775                                                                                  7,561                                   (1,333)         (1,408)                             24,595
 13            43            Amphenol                     US           14,164                                                                                  6,470                                   (765)           1,499                               21,368
 14            #             JPMorgan Chase               US                                          -                                                      23,520                                    (945)           (1,626)                             20,949
 15            12            Chevron                      US           22,799                                                                                  6,182                                   (5,958)         (2,866)                             20,157
 16            #             Intuit                       US                                   9,968                                                         11,354                                    (894)           (712)                               19,716
 17            14            Siemens                      Germany      22,118                                                                                         -                                (5,308)         2,794                               19,604
 18            36            Johnson & Johnson            US           15,622                                                                                  5,551                                   (1,026)         (1,083)                             19,064
 19            24            Deutsche Boerse              Germany      18,149                                                                                         -                                (4,180)         4,772                               18,741
 20            27            Prologis                     US           17,850                                                                                  4,585                                   (1,187)         (2,903)                             18,345
 21            7             CME                          US           26,908                                                                                  7,276                                   (20,132)        3,569                               17,621
 22            41            Verizon Communications       US           14,696                                                                                  6,587                                   (3,455)         (221)                               17,607
 23            18            National Grid                UK           20,462                                                                                         -                                (4,595)         1,736                               17,603
 24            44            Raytheon Technologies        US           13,998                                                                                  3,878                                   (682)           80                                  17,274
 25            31            NatWest                      UK           16,742                                                                                         -                                (4,181)         4,321                               16,882
 26            34            Marriott International       US           16,018                                                                                  5,862                                   (2,950)         (2,849)                             16,081
 27            39            Stryker                      US           14,718                                                                                  2,376                                   (1,465)         34                                  15,663
 28            #             Booz Allen Hamilton          US           10,756                                                                                11,323                                    (603)           (5,944)                             15,532
 29            28            Accenture                    US           17,249                                                                                  7,620                                   (7,179)         (2,310)                             15,380
 Rank          Rank          Company                      Country      Valuation                                                           Purchases                                                   Sales proceeds  Appreciation/     Valuation

31 Oct

(depreciation)
30 Apr
 30 Apr 2025   31 Oct 2024
                                                                   £'000                                                       £'000

                                                                       2024                                                                                                                                            £'000            2025

                                                                       £'000                                                                                                                                                            £'000
 30            #             Walt Disney                  US                                          -                                                      20,126                                    (601)           (4,197)                             15,328
 31            #             Progressive                  US                                          -                                                      14,450                                    (635)           1,366                               15,181
 32            #             Eaton                        US           10,586                                                                                  7,810                                   (435)           (2,792)                             15,169
 33            22            UniCredit                    Italy        18,904                                                                                         -                                (7,181)         3,176                               14,899
 34            #             Dell Technologies            US           7,303                                                                                 14,634                                    (580)           (6,597)                             14,760
 35            25            Oracle                       US           18,142                                                                                  5,593                                   (4,679)         (4,328)                             14,728
 36            33            Roche                        Switzerland  16,287                                                                                  1,890                                   (3,453)         (86)                                14,638
 37            19            SGS                          Switzerland  20,297                                                                                         -                                (3,818)         (1,983)                             14,496
 38            9             UnitedHealth                 US           25,474                                                                                  3,887                                   (7,972)         (6,919)                             14,470
 39            15            Compass                      UK           21,843                                                                                         -                                (8,503)         791                                 14,131
 40            #             Salesforce                   US                                          -                                                      18,037                                    (643)           (3,558)                             13,836
 41            20            TotalEnergies                France       19,844                                                                                         -                                (4,148)         (1,871)                             13,825
 42            #             Trane Technologies           US           9,275                                                                                   5,518                                   (532)           (500)                               13,761
 43            26            Hermès                       France       18,123                                                                                         -                                (7,482)         3,003                               13,644
 44            #             Union Pacific                US                                          -                                                      16,698                                    (531)           (2,942)                             13,225
 45            42            Safran                       France       14,233                                                                                         -                                (3,429)         1,631                               12,435
 46            35            Sanofi                       France       15,978                                                                                         -                                (3,342)         (301)                               12,335
 47            #             Vertex Pharmaceuticals       US           11,013                                                                                  4,571                                   (3,897)         515                                 12,202
 48            #             Sony                         Japan        11,814                                                                                     439                                  (4,681)         4,538                               12,110
 49            32            Informa                      UK           16,585                                                                                         -                                (3,896)         (1,129)                             11,560
 50            48            SAP                          Germany                            12,324                                                                   -                                (3,039)         2,184                               11,469
                                                                                       893,933                                                            342,280                                      (201,815)       (34,208)         1,000,190

 

All securities are equity investments

# Not in top 50 at 31 October 2024

Convertibles and all classes of equity in any one company are treated as one
investment

 

 

 

 Revenue Generated
                                30 April 2025                                                   30 April 2024

                                £million                                                        £million
 North America                  7.6                                                             5.6
 Pan Europe                     4.4                                                             7.9
 Pan Asia                       2.2                                                             3.1
 Japan                          1.9                                                             2.2
 Emerging Markets                                            -                                  0.3
                                ---------                                                       ---------
                                16.1                                                            19.1
                                =====                                                           =====
 Comparatives for 30 April 2024 have been restated for the change in portfolio
 sleeve. UK has been included in Pan Europe and China has been included in Pan
 Asia.
 Source: Janus Henderson

 Regional Breakdown                         Valuation of investments

 Equities excluding cash held

                                30 April 2025                                                   31 October 2024

                                %                                                               %
 North America                  59.9                                                            49.6
 Pan Europe                     21.0                                                            25.6
 Japan                          11.5                                                            13.5
 Pan Asia                       7.6                                                             11.3
                                ---------                                                       ---------
                                100.0                                                           100.0
                                =====                                                           =====
 Source: Janus Henderson

 Sector Breakdown

 As a percentage of the investment portfolio excluding cash
                                30 April 2025                                                   31 October 2024

                                %                                                               %
 Technology                     29.7                                                            27.0
 Industrials                    18.0                                                            16.4
 Financials                     16.1                                                            15.0
 Consumer Discretionary         12.3                                                            12.4
 Healthcare                     9.9                                                             13.1
 Consumer Staples               4.8                                                             5.1
 Energy                         3.0                                                             3.4
 Real Estate                    2.3                                                             2.4
 Utilities                      1.7                                                             3.1
 Telecommunications             1.3                                                             1.3
 Basic Materials                0.9                                                             0.8
                                ---------                                                       ---------
                                100.0                                                           100.0
                                =====                                                           =====
 Source: Janus Henderson

 Neither the contents of the Company's website nor the contents of any website
 accessible from hyperlinks on the Company's website (or any other website) are
 incorporated into, or forms part of, this announcement.

 *********************************

Source: Janus Henderson

 

 

 

Regional Breakdown

Equities excluding cash held

 

            Valuation of investments

30 April 2025

%

31 October 2024

%

North America

59.9

49.6

Pan Europe

21.0

25.6

Japan

11.5

13.5

Pan Asia

7.6

11.3

---------

---------

100.0

100.0

=====

=====

Source: Janus Henderson

 

 

 

Sector Breakdown

As a percentage of the investment portfolio excluding cash

30 April 2025

%

31 October 2024

%

Technology

29.7

27.0

Industrials

18.0

16.4

Financials

16.1

15.0

Consumer Discretionary

12.3

12.4

Healthcare

9.9

13.1

Consumer Staples

4.8

5.1

Energy

3.0

3.4

Real Estate

2.3

2.4

Utilities

1.7

3.1

Telecommunications

1.3

1.3

Basic Materials

0.9

0.8

---------

---------

100.0

100.0

=====

=====

Source: Janus Henderson

 

 

 

 

Neither the contents of the Company's website nor the contents of any website
accessible from hyperlinks on the Company's website (or any other website) are
incorporated into, or forms part of, this announcement.

 

*********************************

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact
rns@lseg.com (mailto:rns@lseg.com)
 or visit
www.rns.com (http://www.rns.com/)
.

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our
Privacy Policy (https://www.lseg.com/privacy-and-cookie-policy)
.   END  IR FLFSERVISFIE

Recent news on Bankers Investment Trust

See all news